Milrinone Lactate
NDC Package 10019-070-01

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Other Packages
    3. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

Milrinone Lactate is a medication used for the short-term treatment of heart failure. Marketed by Baxter Healthcare Corporation, this product is identified by NDC 10019-070 and is authorized under FDA application ANDA075530.

Identification & Billing

NDC Package Code
10019-070-01
Package Description
10 VIAL in 1 PACKAGE / 10 mL in 1 VIAL (10019-070-10)
Product Code
10019-070
11-Digit Billing Format
10019007001

Clinical Specifications

Proprietary Name
Milrinone Lactate
Dosage Form
-
Usage Information
This medication is used for the short-term treatment of heart failure. It works by making your heart beat stronger and by relaxing certain blood vessels so that the amount of blood that is pumped from the heart is increased. This effect may help with symptoms of heart failure (such as shortness of breath, tiredness).

Regulatory & Marketing

Labeler Name
Baxter Healthcare Corporation
FDA Application #
ANDA075530
Marketing Category
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date
05-28-2002
End Marketing Date
06-30-2013
Listing Expiration
06-30-2013
Exclude Flag
D
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Other Available Packages

The following commercial packages are registered under the same Product NDC (10019-070). Click a package code to view its specific billing and regulatory data.

10019-070-02
10 VIAL in 1 PACKAGE / 20 mL in 1 VIAL (10019-070-20)

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 10019-070-01 identifies a specific commercial package of 10 vial in 1 package / 10 ml in 1 vial (10019-070-10) of Milrinone Lactate, labeled by Baxter Healthcare Corporation. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Baxter Healthcare Corporation on May 28, 2002. The current certification is valid through June 30, 2013.

What are the primary indications for this medication?

This medication is used for the short-term treatment of heart failure. It works by making your heart beat stronger and by relaxing certain blood vessels so that the amount of blood that is pumped from the heart is increased. This effect may help with symptoms of heart failure (such as shortness of breath, tiredness).

How is this Baxter Healthcare Corporation product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 10019007001. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
10019-070-01
11-Digit CMS (5-4-2)
10019-0070-01

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.